Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10845942 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
Condition: Multiple Myeloma
Intervention: Procedure: Maintenance with lower doses of lenalidomide and dexamethasone

Indicates status has not been verified in more than two years